CYTK — Cytokinetics, Incorporated stock price, charts and financials

QT59Cytokinetics, Incorporated

Cytokinetics, Incorporated (NASDAQ: CYTK) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
78.61
+2.16+2.83%
CYTKQT59Cytokinetics, Incorporated·NASDAQ
78.61+2.83%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 30, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 23, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 14, 20264Statement of changes in beneficial ownership
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership